Apoptosis induced by an antagonist peptide against HPV16 E7 in vitro and in vivo via restoration of p53

Apoptosis

Volumn 16, Issue 6, 2011, Pages 606-618

  Guo, Caiping ^a   Liu, Kewei ^a   Zheng, Yi ^a   Luo, Haibo ^a   Chen, Hongbo ^a   Huang, Laiqiang ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

Antagonist peptide; Apoptosis; Cervical cancer; E7 protein; HPV; p53

Indexed keywords

ANTINEOPLASTIC AGENT; PEPTIDE; PEPTIDE PEP 7; PROTEIN P21; PROTEIN P53; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; DRUG PROTEIN BINDING; FEMALE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TUMOR XENOGRAFT; UTERINE CERVIX CANCER;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MICE; MICE, INBRED BALB C; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS INFECTIONS; PEPTIDES; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; MUS MUSCULUS;

EID: 79955838325     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-011-0594-0     Document Type: Article

References (39)

1. MH Schiffman LA Brinton 1995 The epidemiology of cervical carcinogenesis Cancer 76 10 Suppl 1888 1901 8634980 10.1002/1097-0142(19951115)76:10+<1888:: AID-CNCR2820761305>3.0.CO;2-H 1:STN:280:DyaK283ivF2mtA%3D%3D
2. N Chunlian G Guolan H Jie L Hua C Heping H Ming 2008 Human papillomavirus 16 E6, E7 siRNAs inhibit proliferation and induce apoptosis of SiHa cervical cancer cells Chin J Cancer Res 20 4 6
3. X Liu J Roberts A Dakic Y Zhang R Schlegel 2008 HPV E7 contributes to the telomerase activity of immortalized and tumorigenic cells and augments E6-induced hTERT promoter function Virology 375 2 611 623 18367227 10.1016/j.virol.2008.02.025 1:CAS:528:DC%2BD1cXlvF2rsbg%3D
4. NR Chu HB Wu T Wu LJ Boux MI Siegel LA Mizzen 2000 Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guerin (BCG) hsp65 and HPV16 E7 Clin Exp Immunol 121 2 216 225 10931134 10.1046/j.1365-2249. 2000.01293.x 1:CAS:528:DC%2BD3cXlvFymur0%3D (Pubitemid 30662070)
5. AM Kaufmann PL Stern EM Rankin H Sommer V Nuessler A Schneider, et al. 2002 Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer Clin Cancer Res 8 12 3676 3685 12473576 1:CAS:528:DC%2BD38XpslCjtr0%3D (Pubitemid 35424757)
6. T Veldman I Horikawa JC Barrett R Schlegel 2001 Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein J Virol 75 9 4467 4472 11287602 10.1128/JVI.75.9.4467-4472.2001 1:CAS:528:DC%2BD3MXivFOkurY%3D (Pubitemid 32410165)
7. A Nishimura T Nakahara T Ueno K Sasaki S Yoshida S Kyo, et al. 2006 Requirement of E7 oncoprotein for viability of HeLa cells Microbes Infect 8 4 984 993 16500131 10.1016/j.micinf.2005.10.015 1:CAS:528:DC%2BD28XktVGgtL0%3D
8. BA Werness AJ Levine PM Howley 1990 Association of human papillomavirus types 16 and 18 E6 proteins with p53 Science 248 4951 76 79 2157286 10.1126/science.2157286 1:CAS:528:DyaK3cXktF2ltL0%3D
9. M Scheffner JM Huibregtse RD Vierstra PM Howley 1993 The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 Cell 75 3 495 505 8221889 10.1016/0092-8674(93)90384-3 1:CAS:528: DyaK2cXlvFKm (Pubitemid 23335075)
10. M Scheffner BA Werness JM Huibregtse AJ Levine PM Howley 1990 The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 Cell 63 6 1129 1136 2175676 10.1016/0092-8674(90)90409-8 1:CAS:528:DyaK3MXls12itg%3D%3D (Pubitemid 120035062)
11. RM Alani K Munger 1998 Human papillomaviruses and associated malignancies J Clin Oncol 16 1 330 337 9440761 1:STN:280:DyaK1c7gtFOisw%3D%3D (Pubitemid 28041617)
12. K Munger A Baldwin KM Edwards H Hayakawa CL Nguyen M Owens, et al. 2004 Mechanisms of human papillomavirus-induced oncogenesis J Virol 78 21 11451 11460 15479788 10.1128/JVI.78.21.11451-11460.2004 (Pubitemid 39390733)
13. JT Thomas LA Laimins 1998 Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint J Virol 72 2 1131 1137 9445009 1:CAS:528:DyaK1cXlt1OmsQ%3D%3D (Pubitemid 28116894)
14. H Pan AE Griep 1995 Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development Genes Dev 9 17 2157 2169 7657167 10.1101/gad.9.17.2157 1:CAS:528:DyaK2MXotVOnu7g%3D
15. DL Jones K Munger 1997 Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein J Virol 71 4 2905 2912 9060648 1:CAS:528:DyaK2sXhvVGnsbs%3D (Pubitemid 27119932)
16. JA Puthenveettil SM Frederickson CA Reznikoff 1996 Apoptosis in human papillomavirus16 E7-, but not E6-immortalized human uroepithelial cells Oncogene 13 6 1123 1131 8808685 1:CAS:528:DyaK28XmtFekurc%3D (Pubitemid 26343564)
17. H Stoppler MC Stoppler E Johnson CM Simbulan-Rosenthal ME Smulson S Iyer, et al. 1998 The E7 protein of human papillomavirus type 16 sensitizes primary human keratinocytes to apoptosis Oncogene 17 10 1207 1214 9771963 10.1038/sj.onc.1202053 1:CAS:528:DyaK1cXmt1antrw%3D (Pubitemid 28446160)
18. DA Thompson V Zacny GS Belinsky M Classon DL Jones R Schlegel, et al. 2001 The HPV E7 oncoprotein inhibits tumor necrosis factor alpha-mediated apoptosis in normal human fibroblasts Oncogene 20 28 3629 3640 11439326 10.1038/sj.onc.1204483 1:CAS:528:DC%2BD3MXltVKnsL4%3D (Pubitemid 32624955)
19. SS Magal A Jackman XF Pei R Schlegel L Sherman 1998 Induction of apoptosis in human keratinocytes containing mutated p53 alleles and its inhibition by both the E6 and E7 oncoproteins Int J Cancer 75 1 96 104 9426696 10.1002/(SICI)1097-0215(19980105)75:1<96::AID-IJC15>3.0.CO;2-B 1:CAS:528:DyaK1cXjsFyjsQ%3D%3D (Pubitemid 28113983)
20. A Severino C Abbruzzese L Manente AA Valderas S Mattarocci A Federico, et al. 2007 Human papillomavirus-16 E7 interacts with Siva-1 and modulates apoptosis in HaCaT human immortalized keratinocytes J Cell Physiol 212 1 118 125 17348035 10.1002/jcp.21011 1:CAS:528:DC%2BD2sXmtVWktL0%3D (Pubitemid 46867593)
21. JH Shim KH Kim YS Cho HS Choi EY Song PK Myung, et al. 2008 Protective effect of oxidative stress in HaCaT keratinocytes expressing E7 oncogene Amino Acids 34 1 135 141 17334903 10.1007/s00726-007-0499-y 1:CAS:528: DC%2BD1cXlt1Cltw%3D%3D
22. Parkin DM, Bray F (2006) Chapter 2: the burden of HPV-related cancers. Vaccine 24(Suppl 3):S3/11-25
23. PG Rose BN Bundy EB Watkins JT Thigpen G Deppe MA Maiman, et al. 1999 Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 15 1144 1153 10202165 10.1056/ NEJM199904153401502 1:CAS:528:DyaK1MXislKgtLs%3D (Pubitemid 29177873)
24. F Wang-Johanning GY Gillespie J Grim C Rancourt RD Alvarez GP Siegal, et al. 1998 Intracellular expression of a single-chain antibody directed against human papillomavirus type 16 E7 oncoprotein achieves targeted antineoplastic effects Cancer Res 58 9 1893 1900 9581830 1:CAS:528:DyaK1cXislentrY%3D (Pubitemid 28217464)
25. C Giovane G Trave A Briones Y Lutz B Wasylyk E Weiss 1999 Targetting of the N-terminal domain of the human papillomavirus type 16 E6 oncoprotein with monomeric ScFvs blocks the E6-mediated degradation of cellular p53 J Mol Recognit 12 2 141 152 10398405 10.1002/(SICI)1099-1352(199903/04)12:2<141:: AID-JMR453>3.0.CO;2-O 1:CAS:528:DyaK1MXisF2jtrg%3D (Pubitemid 29178089)
26. S Nauenburg W Zwerschke P Jansen-Durr 2001 Induction of apoptosis in cervical carcinoma cells by peptide aptamers that bind to the HPV-16 E7 oncoprotein FASEB J 15 3 592 594 11259377 1:CAS:528:DC%2BD3MXitFWms70%3D
27. Stanley M (2003) Chapter 17: genital human papillomavirus infections-current and prospective therapies. J Natl Cancer Inst Monogr (31):117-124
28. N Sima S Wang W Wang D Kong Q Xu X Tian, et al. 2007 Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells Gynecol Oncol 106 2 299 304 17586029 10.1016/j.ygyno.2007.04.039 1:CAS:528:DC%2BD2sXot1ygurs%3D (Pubitemid 47087935)
29. N Sima W Wang D Kong D Deng Q Xu J Zhou, et al. 2008 RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53 Apoptosis 13 2 273 281 18060502 10.1007/s10495-007-0163-8 1:CAS:528:DC%2BD1cXht1SisLw%3D
30. S Wu L Meng S Wang W Wang L Xi X Tian, et al. 2006 Reversal of the malignant phenotype of cervical cancer CaSki cells through adeno-associated virus-mediated delivery of HPV16 E7 antisense RNA Clin Cancer Res 12 7 Pt 1 2032 2037 16609012 10.1158/1078-0432.CCR-05-2567 1:CAS:528:DC%2BD28XjtlCiu7o%3D
31. M Jiang J Milner 2002 Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference Oncogene 21 39 6041 6048 12203116 10.1038/sj.onc.1205878 1:CAS:528:DC%2BD38XmsFGqsL4%3D
32. K Hamada T Shirakawa A Gotoh JA Roth M Follen 2006 Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer Gynecol Oncol 103 3 820 830 16908054 10.1016/j.ygyno.2006.06.035 1:CAS:528:DC%2BD28Xht1KgtLbF (Pubitemid 44821337)
33. EJ Shillitoe P Kamath Z Chen 1994 Papillomaviruses as targets for cancer gene therapy Cancer Gene Ther 1 3 193 204 7621251 1:CAS:528:DyaK2MXhvFOhu7g%3D
34. T Aaltonen J Adelman T Akimoto MG Albrow B Alvarez Gonzalez S Amerio, et al. 2008 Search for the Higgs boson produced in association with Z → l+l in pp collisions at sqrt[s] = 1.96 TeV Phys Rev Lett 101 25 251803 19113696 10.1103/PhysRevLett.101.251803
35. MG Dona C Giorgi L Accardi 2007 Characterization of antibodies in single-chain format against the E7 oncoprotein of the human papillomavirus type 16 and their improvement by mutagenesis BMC Cancer 7 25 17266749 10.1186/1471-2407-7-25
36. H Niwa AL Wentzel M Li WE Gooding VW Lui JR Grandis 2003 Antitumor effects of epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck Clin Cancer Res 9 13 5028 5035 14581378 1:CAS:528:DC%2BD3sXosVGjtbs%3D (Pubitemid 37323310)
37. E Passegue AJ Wagers S Giuriato WC Anderson IL Weissman 2005 Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates J Exp Med 202 11 1599 1611 16330818 10.1084/jem.20050967 1:CAS:528:DC%2BD2MXhtlSqtLbL (Pubitemid 41746605)
38. P Jares E Campo M Pinyol F Bosch R Miquel PL Fernandez, et al. 1996 Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity Am J Pathol 148 5 1591 1600 8623927 1:STN:280:DyaK283gvVWgtg%3D%3D
39. WS El-Deiry T Tokino VE Velculescu DB Levy R Parsons JM Trent, et al. 1993 WAF1, a potential mediator of p53 tumor suppression Cell 75 4 817 825 8242752 10.1016/0092-8674(93)90500-P 1:CAS:528:DyaK2cXpslGguw%3D%3D (Pubitemid 23346378)